Crossref
Androgen Receptor Expression-Guided Optimization of Neoadjuvant Therapy and Prognostic Modeling in HER2-Low Triple-Negative Breast Cancer
Research · 2026 · 1 (1)
DOI: 10.65613/739880 ↗At a glance
Journal article in Research, 2026. Written by Minyue Du and 3 co-authors.
Abstract (original language)
No hay resumen disponible.
Cite
APA
Du, M., Wang, L., Han, S., & Huang, C. (2026). Androgen Receptor Expression-Guided Optimization of Neoadjuvant Therapy and Prognostic Modeling in HER2-Low Triple-Negative Breast Cancer. Research, 1(1). https://doi.org/10.65613/739880
Vancouver
Du M, Wang L, Han S, Huang C. Androgen Receptor Expression-Guided Optimization of Neoadjuvant Therapy and Prognostic Modeling in HER2-Low Triple-Negative Breast Cancer. Research. 2026;1(1). doi:10.65613/739880
BibTeX
@article{Du2026,
author = {Du, Minyue and Wang, Lan and Han, Shuo and Huang, Can},
title = {Androgen Receptor Expression-Guided Optimization of Neoadjuvant Therapy and Prognostic Modeling in HER2-Low Triple-Negative Breast Cancer},
journal = {Research},
year = {2026},
volume = {1},
number = {1},
doi = {10.65613/739880}
}
EUVIMED